![]() |
| |||||||
| Clinical Pharmacy Post any relevant clinical pharmacy topics or questions here. |
![]() |
| | LinkBack | Thread Tools | Display Modes |
| |||
|
pharmacokinetic changes include: gentamicin elimination (increase or decrease?), gentimicin volume of distribution willl (decrease or increase?) thanks, Jeff if you want to give me a source i will go find it as well |
| |||
|
sorry my fault. please pick what would happen..increase or decrease. pharmacokinetic changes after consumed include: gentamicin elimination (increase or decrease?), gentimicin volume of distribution willl (decrease or increase?) |
| |||
| Quote:
Elimination is mostly by kidney filtration, so any drug slowing that down will decrease elimination and extend the half life, as would poor kidney function. Gentamicin, along with the rest of the aminoglycosides have known toxicity potential and are usually not the first choice. (neurotoxicity and ototoxicity) The scientifically curious can have a look at the UK-SPC available at... The electronic Medicines Compendium This might also help. Pharmacodynamics of Gentamicin Google works for me - every time. |
| |||
|
So Pharmanaut, then from your post. you are saying the above scenario would occur with a woman with chronic renal insafficiency with edema. after taking the drug we would expect.... as gentamicin elimination ( decreases?), gentimicin volume of distribution willl (increases?) right??? |
| |||
|
oh,,funny..dont worry im a student doing some research. this is not a functional question. i should have said that. i am not a pharmacist nor am i in pharm school nor do i plan on taking the drug or reomending it to anyone.
|